CASP3 and acute myeloid leukemia: Given that CalPegA did not induce cell death in AML cells, as indicated by trypan blue exclusion assay and the absence of caspase-3 and PARP cleavage in immunoblot analysis, we next sought to assess the cytostatic effects of CalPegA.